CIRRHOSIS

作品数:1423被引量:7223H指数:35
导出分析报告
相关领域:医药卫生更多>>
相关作者:陆忠华于亚杰陈菊娣居朝霞周美芳更多>>
相关机构:中华医学会解放军第302医院香港大学复旦大学更多>>
相关期刊:更多>>
相关基金:国家自然科学基金国家重点基础研究发展计划国家高技术研究发展计划北京市自然科学基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 主题=LIVERx
条 记 录,以下是1-10
视图:
排序:
The Failure Rate of Liver Stiffness Measured by Vibrationcontrolled Transient Elastography in the United States and Relevant Factors
《Journal of Clinical and Translational Hepatology》2024年第12期1067-1069,共3页Ruoqi Zhou Jiyang Chen Rui Huang Yida Yang Yu Shi 
supported by the National Key Research and Development Program of China(No.2022YFC2304501 and No.2021YFC2301800);the Fundamental Research Funds for the Central Universities(2023QZJH50);the Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission(No.2022RC141);the Chinese National Natural Science Foundation(No.81870425).
Citation of this article:Zhou R,Chen J,Huang R,Yang Y,Shi Y.The Failure Rate of Liver Stiffness Measured by Vibrationcontrolled Transient Elastography in the United States and Relevant Factors.J Clin Transl Hepatol 20...
关键词:LIVER CIRRHOSIS Vibration 
Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients
《World Journal of Hepatology》2024年第11期1321-1330,共10页Wei-Chun Lin Ke Lin Ming-Kai Li Xiao Liu Yi-Fei Huang Xing Wang Bin Wu 
Supported by the National Natural Science Foundation of China,No.82070574。
BACKGROUND Whether patients with compensated cirrhosis and low-level viremia(LLV)of hepatitis B should receive antiviral therapy(AVT)is still controversial,and published results are inconsistent.AIM To investigate the...
关键词:Low level of hepatitis B viremia Compensated cirrhosis Hepatocellular carcinoma Hepatic decompensation Liver-related events 
Fat necrosis of liver in a patient with mixed type liver cirrhosis
《Hepatobiliary & Pancreatic Diseases International》2024年第5期535-537,共3页Li-Fang Shao Xiao-Min Shen Wei Yu 
To the Editor: Fatty liver diseases, including nonalcoholic fatty liver disease and alcohol related fatty liver disease, have become a major public health concern [ 1, 2 ]. Fatty liver diseases have been shown to prog...
关键词:CIRRHOSIS DISEASES LIVER 
Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis
《World Journal of Hepatology》2024年第5期822-831,共10页Irina Efremova Roman Maslennikov Elena Poluektova Oleg Medvedev Anna Kudryavtseva George Krasnov Maria Fedorova Filipp Romanikhin Maria Zharkova Oxana Zolnikova Gyunay Bagieva Vladimir Ivashkin 
approved by the Ethics Committee of Sechenov University and performed in accordance with the Declaration of Helsinki.
BACKGROUND The gut–liver axis and bacterial translocation are important in cirrhosis,but there is no available universal biomarker of cellular bacterial translocation,for which presepsin may be a candidate.AIM To eva...
关键词:DYSBIOSIS GUT Intestinal permeability Leaky gut Gut-liver axis LIVER MICROBIOTA 
Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis被引量:1
《World Journal of Gastroenterology》2023年第47期6165-6167,共3页Matthew Peverelle Jonathan Ng James Peverelle Ryan D.Hirsch Adam Testro 
There is rapidly increasing uptake of GLP-1 (glucagon-like peptide-1) agonistssuch as semaglutide worldwide for weight loss and management of non-alcoholicsteatohepatitis (NASH). remains a paucity of safety data in th...
关键词:Semaglutide Non-alcoholic steatohepatitis CIRRHOSIS Non-alcoholic steatohepatitis cirrhosis Glucagon-like peptide 1 agonists Weight loss 
HCC case management-related challenges:Think outside the box!
《iLIVER》2023年第3期143-145,共3页Nourhan Badwei 
To the Editor,Hepatocellular carcinoma(HCC)is a common primary liver malig-nancy that mainly occurs in chronic liver disease patients with under-lying cirrhosis.HCC incidence has increased globally in the last two dec...
关键词:LIVER OUTSIDE CIRRHOSIS 
Single-cell RNA-seq Revealed that Altered Tumor Infiltrating Lymphocytes in Cirrhotic Liver Indicate Development of Hepatocellular Carcinoma被引量:1
《Journal of Clinical and Translational Hepatology》2023年第4期850-862,共13页Jingxian Duan Peng Zhu Yong Zhang Tianhao Mu Yingqiang Li Rui Xiong Su Chen Yingmei Li Zhicheng Li Shifu Chen Lei Zhang 
This study received financial support from the Key-Area Research and Development Program of Guangdong Province(No.2021B0101420006);the National Natural Science Foundation of China(Nos.62201557,U20A20171,12126608,82073090);the Shenzhen Science and Technology Innovation Committee Technical Research Projects(Nos.JSGG20180703164202084,KQJSCX20180330124428928,JSGG20180508152646606);the Guangdong Basic and Applied Basic Research Foundation(Nos.2020B1515120046,2021A1515110585);Shanxi Province“136”Revitalization Medical Project Construction Funds.
Background and Aims:Cirrhosis is the precursor lesion for most hepatocellular carcinoma(HCC)cases.However,no biomarker effectively predicted HCC initiation before diagnosis by imaging.We aimed to investigate the hallm...
关键词:Immune microenvironment Single-cell RNA sequencing CIRRHOSIS Hepatocellular carcinoma LIVER 
Synchronous Double Primary Combined Hepatocellularcholangiocarcinoma and Cholangiolocarcinoma in a Cirrhotic Liver
《Journal of Clinical and Translational Hepatology》2023年第4期991-997,共7页Masahiro Sakata Koji Kitada Rika Omote Hiroshi Sonobe Masashi Utsumi Naoyuki Tokunaga Takashi Fushimi Ryota Nagao Tatsuro Sakata Toshihiko Kaneyoshi Tatsuya Toyokawa Masaru Inagaki 
Both combined hepatocellular-cholangiocarcinoma(cHCCCCA)and cholangiolocarcinoma are rare primary liver cancers.cHCC-CCA is believed to originate from transformed hepatocellular carcinoma or liver stem/progenitor cell...
关键词:Bile duct neoplasms Combined hepatocellular-cholangiocarcinoma Cholangiolocarcinoma CIRRHOSIS Liver neoplasms 
Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver被引量:2
《World Journal of Gastroenterology》2022年第36期5380-5382,共3页Tarana Gupta 
The burden of non-alcoholic steatohepatitis (NASH) related hepatocellularcarcinoma (HCC) is drawing attention due to the emerging epidemic of obesityand metabolic syndrome and is expected to increase in the near futur...
关键词:Non-alcoholic steatohepatitis Hepatocellular carcinoma CIRRHOSIS Genetic factors Lifestyle factors SURVEILLANCE 
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System:Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis被引量:7
《World Journal of Gastroenterology》2022年第27期3488-3502,共15页Gianpaolo Vidili Marco Arru Giuliana Solinas Diego Francesco Calvisi Pierluigi Meloni Assunta Sauchella Davide Turilli Claudio Fabio Antonio Cossu Giordano Madeddu Sergio Babudieri Maria Assunta Zocco Giovanni Iannetti Enza Di Lembo Alessandro Palmerio Delitala Roberto Manetti 
Supported by the Fondazione di Sardegna,No.FDS2019VIDILI;the University of Sassari,No.FAR2019.
BACKGROUND Contrast-enhanced ultrasound(CEUS)is considered a secondary examination compared to computed tomography(CT)and magnetic resonance imaging(MRI)in the diagnosis of hepatocellular carcinoma(HCC),due to the ris...
关键词:Contrast-enhanced ultrasound Liver Imaging Reporting and Data System Hepatocellular carcinoma Intrahepatic cholangiocarcinoma CIRRHOSIS Contrast-enhanced ultrasound LIVER 
检索报告 对象比较 聚类工具 使用帮助 返回顶部